✨ ✨ ✨ To kick off an exciting new week, I wanted to highlight a company who are thriving in a difficult market, overcoming challenges, and excelling to new heights..✨ ✨ ✨
🥁 🥁Introducing Serán BioScience
🔎 Serán BioScience is a rapidly growing contract development and manufacturing organization (CDMO) founded in 2016. Their expertise, and some key facts are listed below:
🔵 The company have over 200 people at their Bend Campus, with an upcoming Commercial expansion which will increase that number dramatically. Their site includes 10 buildings and a combined 90,000 sq ft of space!
🔵They completed an expansion of their Bend, Oregon facility significantly in September 2024, adding eight state-of-the-art suites, increasing their clinical manufacturing capacity by 130%. This allows them to handle late-stage clinical trials and larger scale manufacturing projects
💊 They have positioned themselves as a leader in drug delivery technologies, with expertise in areas such as oral solid, spray drying, nano-milling, hot melt extrusion, and advanced particle engineering solutions including dry and wet granulation, twin-screw melt extrusion, tablet compression, tablet coating, encapsulation, and clinical packaging and labelling. This expertise allows them to truly be a market leader in complex inhaled drug delivery systems.
📰 September has been a big month for Serán with the announcement that they had completed their expansion of 8 facilities increasing their capabilities. In addition to this, they also announced a $200 million investment from Bain Capital, led by Will Cozean for the build-out of their first commercial production plant, which is slated for completion in 2026.
Their current investor Vivo Capital remain a close partner, and key shareholder throughout this process.
In a statement their CEO said:
"This transaction is a significant milestone in Serán’s evolution, which will enable us to rapidly scale our clinical manufacturing capability to support launches of new medicines, as well as serve new clients seeking state-of-the-art commercial capacity. We are proud to have the additional support and resources of a preeminent life sciences investor in Bain Capital who shares our vision for expanding Serán’s science-based drug development capabilities to enable commercial manufacturing of complex medicines,”
Congrats to Will Cozean, and Dan Smithey, PhD on this great addition to Serán BioScience's capabilities!
#cdmo #formulation #spraydrying #investment #expansion #innovation
Human Resources Consultant
5moI enjoyed designing and running this session for Maxion Therapeutics and was pleased with what everybody seemed to get out of the session and the fact that the MBTI based conversations continued in the bar afterwards! This is a very talented team and and I really enjoy working with them all to help them achieve their goals.